Fed. Circ. Rules Apotex's Fosamax Appeal Moot
Since generic versions of Merck & Co.'s osteoporosis drug Fosamax went on sale in February, a lawsuit involving Canadian generics maker Apotex Inc. is moot, the U.S. Court of Appeals for...To view the full article, register now.
Already a subscriber? Click here to view full article